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Abstract: Polycaprolactone (PCL) polyester and segmented aliphatic polyester urethanes 
based on PCL soft segment have been thoroughly investigated as biodegradable scaffolds 
for tissue engineering. Although proven beneficial as long term implants, these materials 
degrade very slowly and are therefore not suitable in applications in which scaffold support 
is needed for a shorter time. A recently developed class of polyacylurethanes (PAUs) is 
expected to fulfill such requirements. Our aim was to assess in vitro the degradation of 
PAUs and evaluate their suitability as temporary scaffold materials to support soft tissue 
repair. With both a mass loss of 2.5–3.0% and a decrease in molar mass of approx. 35% 
over a period of 80 days, PAUs were shown to degrade via both bulk and surface erosion 
mechanisms. Fourier Transform Infra Red (FTIR) spectroscopy was successfully applied to 
study the extent of PAUs microphase separation during in vitro degradation. The 
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microphase separated morphology of PAU1000 (molar mass of the oligocaprolactone soft 
segment = 1000 g/mol) provided this polymer with mechano-physical characteristics that 
would render it a suitable material for constructs and devices. PAU1000 exhibited excellent 
haemocompatibility in vitro. In addition, PAU1000 supported both adhesion and 
proliferation of vascular endothelial cells and this could be further enhanced by pre-coating 
of PAU1000 with fibronectin (Fn). The contact angle of PAU1000 decreased both with  
in vitro degradation and by incubation in biological fluids. In endothelial cell culture 
medium the contact angle reached 60°, which is optimal for cell adhesion. Taken together, 
these results support the application of PAU1000 in the field of soft tissue repair as a 
temporary degradable scaffold. 
Keywords: biodegradable polymers; tissue engineering; biomedical polyurethanes; 
hydrolytic degradation; acylurethanes; blood compatibility; endothelial cells 
 
1. Introduction 
Degradable polymers are preferred candidates for designing therapeutic devices to treat missing or 
damaged soft tissues. Being FDA approved, polycaprolactone (PCL) has been intensively investigated 
as temporary scaffold biomaterial. However, PCL suffers from significant drawbacks. PCL is found to 
degrade very slowly both in vitro and in vivo, with almost no mass loss or decrease in molar mass for 
at least 6 months of degradation [1,2]. In addition, in order to achieve good mechanical properties, the 
molar mass of PCL has to be relatively high which leads to an increase in crystalline fraction of this 
semi-crystalline polyester. The latter might cause an obstacle for healthy regeneration in vivo [3,4]. 
Our aim was to develop a biomaterial with tunable (degradation) properties and surface 
characteristics that allow for cell adhesion to serve as temporary support in soft tissue regeneration. 
Polyurethanes possess good mechanical properties and blood compatibility, which have made them 
attractive for their use for manufacture of biomedical devices [5]. The possibility to alter their 
mechanical properties by changing the ratio between the constituent components, so-called soft 
segments (polyether, polyester, and polycarbonate) and hard segments (aliphatic or aromatic 
diisocyanates), renders them very useful in a variety of materials with different requirements. 
To the best of our knowledge Endo et al. [6] have described polyacylurethanes in literature for the 
first time in 1994. The polymers were prepared by the polyaddition of bis(N-acyl isocyanates) with 
low molecular weight diols and polyether diols. The most interesting feature of this polymerization 
was the high reactivity under mild conditions of the bis(N-acyl isocyanates) towards the polyether 
diols without the use of additional catalysts.  
In a patent of 1995 Yabuta and Urano claimed the preparation of polyacylurethanes where the diol 
could be a polycaprolactone prepolymer, introducing this class of polymers in the area of thermoplastic 
elastomers [7]. However, the procedure described involved quite high temperatures and long reaction 
times and resulted “preferably” in rather low molar mass polymers. Apparently also preferred was the 
use of self-condensing unsymmetrical monomers containing only one acylisocyanate group. The 
polymers have been characterized as easy-degradable. 




Recently, polyacylurethanes (PAUs) have been developed in our laboratory [8,9]. These materials 
were produced without the use of any toxic catalysts of which remnants might limit biomedical use. 
Polyacylurethanes are synthesized with terephthaloyl diisocyanate (TPHDI), which is expected not 
only to enhance materials mechanical properties due to improved micro-phase separation [10], but is 
also expected to result in non-toxic degradation products [11]. The acyl functionality contributes to the 
greater reactivity of TPHDI [12] and is expected to hydrolyze relatively fast [13]. 
The goal of this research was to assess the hydrolytical degradation of PAUs, with an accent on the 
mechanism of PAU hydrolysis and microphase separation, and to evaluate these materials for 
application in regenerative medicine as a biodegradable scaffold. Describing the degradation of PAUs 
in vitro will be used as a starting point to explain its in vivo behavior in the future. 
In this study, we show the results of the degradation study of PAUs with different lengths of the 
oligo(ε-caprolactone) soft segments (Number average molar mass = 1000, 1500 and 2000 g/mol,  
PDI = 1.69, 1.82 and 1.90, respectively). PAU characterization included monitoring mass loss, molar 
masses, and thermal and surface properties of PAUs upon a degradation period of 80 days. The 
microphase separation of PAUs was analyzed by utilizing Fourier Transform Infra Red (FTIR) 
spectroscopy. PAU1000 (molar mass of the oligocaprolactone soft segment = 1000 g/mol) was 
selected as the potential scaffold material to be used in regenerative medicine due to its optimal 
behavior during hydrolytic degradation and suitable micro-phase separation behavior. On this 
particular PAU composition, a series of biological assays were performed to test cytotoxicity and 
haemocompatibility. Human umbilical vein derived endothelial cells (HUVEC) were used for in vitro 
cell adhesion and proliferation experiments. Since both cell adhesion and blood interactions with 
biomaterials take place in the material-protein (cell) interface [14,15], surface properties of PAU1000 
were also investigated. 
2. Results and Discussion 
2.1. Mass Loss and Molar Mass Change 
Polyester urethanes are believed to undergo hydrolytic degradation via two different mechanisms 
identified as bulk degradation and surface erosion [16,17]. Bulk degradation is characterized by an 
overall decrease of molar mass if random chain scission is occurring. Surface erosion is the process 
where hydrolysis removes only polymeric chains from the outer layer of the material and this leaves 
the bulk of the material untouched [16]. Surface erosion is favored for many applications of polymeric 
biomaterials (e.g., controlled drug delivery), because the material properties remain virtually intact 
since degradation proceeds through removal of very thin layers of the material. 
For all three PAUs, mass loss showed a similar pattern, with a 2.5–3.0 wt% decrease in mass at the 
final time point (Figure 1), which is relatively high, especially when compared to other PCL-based 
materials that are intended for similar applications and which show almost no mass loss even for more 
than a year [1,18]. The apparent high mass loss at the first incubation time point (5 days) can be 
attributed to different sample manipulation of the incubation samples compared to the non-incubated 
samples. During preparations for the degradation study (see Section 3.4) prior to weighing, samples 
were exposed to air and thus may have absorbed water. Therefore, by calculating the linear fit, we only 




compared the mass loss trends of the three PAUs and calculated the mass loss at the end of the 
examination period (day 80). Since the potential impurities and residual non-reacted material were 
removed by means of Soxhlet extraction with n-hexane, the observed mass loss upon incubation can 
only be ascribed to PAU degradation. The PAU films changed from flexible to brittle and fragile with 
the course of degradation (Figure 1). 
Figure 1. Mass loss of polyacylurethane (PAU) films with different soft segment lengths at 
37 °C in phosphate buffer (pH = 7.2). (○) PAU1000; (■) PAU1500 and (▼) PAU2000. 
 
The degradation was accompanied by molar mass decrease, indicating that chain scission in bulk 
had occurred additionally. The molar mass of degraded PAUs decreased approximately 32% for 
PAU1000 and PAU1500, to 38% for PAU2000 compared to the non-degraded samples (data not 
shown). It is generally believed that in vitro degradation of polyester urethanes proceeds via random 
scission of the ester bond of the polyester soft segment. Pitt et al. [19] derived the following equation 






= ×  (1) 
or in its linearized form: 
0
n nln( M ) ln( M ) k t= − ×  (2) 
where Mn [gmol−1] is the number average molar mass of the polymer at any time point, Mn0 is the 
initial number average molar mass [g mol−1], k is the ester hydrolysis rate constant [day−1] and t is the 
degradation time [day]. If we assume that the above described model is applicable for PAU 
degradation, then values of ln(Mn0) of PAUs as a function of t can be described by a linear function 
(Figure 2). 
However, when fit parameters were analyzed, r2 value for PAU1000 and PAU1500 fit were ~0.6 
which indicated a poor fit. This further implied that the PAU degradation proceeded not only via 
scission of ester bonds of the PCL soft segment. Water can attack the following functional groups: 
Ester groups of the soft segments, acyl groups of the hard segments and urethane groups of the hard 
segments (Figure 3). As a result, aliphatic carboxylic acids, aromatic carboxylic acids, aliphatic 




alcohols and primary amides can be formed. Both hydrolysis of the soft segment esters and acyl 
urethane groups are acid catalyzed and expected to contribute greatly to PAU degradation. 
Figure 2. Decrease of PAUs’ molar mass in the course of hydrolytic degradation.  
(a) PAU1000 compared to PCL1000-PU; (b) PAU1500 compared to PCL1600-PU;  
(c) PAU2000 compared to PCL2300-PU. Data set for PCL-PUs was calculated assuming 
the same Mn0 and oligodiol molar mass of corresponding PAUs and hydrolysis rate 
constant (k) value for Polycaprolactone (PCL)-PUs as given by Heijkants et al. [18]. 
 




Figure 3. Hard segment hydrolysis. 
 
The observed deviation of the proposed pseudo-linear autocatalytic model and degradation of PAUs 
originates from the fact that the basic assumptions for this model were not fulfilled. The autocatalytic 
model was derived based on the following assumptions: (1) extent of chain scission is small, (2) only 
ester bonds hydrolyze and (3) there is no mass loss [19]. PAUs did loose mass upon degradation and in 
addition to the ester groups of the soft segment, acylurethane groups also might have hydrolyzed. Even 
though they were both composed of the same molar mass of the PCL soft segment, PAUs degraded 
much faster than PCL-PUs based on a BDI hard segment [18] (Figure 2). This can be explained by the 
chemical nature of the acylurethane moiety and the lower degree of microphase separation of PAUs 
compared to the PCL-PUs (see Section 2.3 for details). 
The combination of mass loss and decrease of molar mass indicates that the hydrolytic degradation 
of PAUs occurs with combined bulk and surface erosion mechanisms. 
2.2. Thermal Properties of PAUs Upon Degradation 
Three PAUs with different PCL-oligodiol molar masses (PAU1000, PAU1500 and PAU2000) 
exhibited different melting endotherms (Figure 4). 
Figure 4. Thermal properties of PAUs upon degradation at 37 °C in phosphate buffer 
solution (pH = 7.2). Heating endotherms (1st heating scan) of PAUs with different  
PCL-oligodiol lengths non-degraded (0 days) and at the end of the degradation period  
(80 days). Tg-glass transition temperature; Tm,,SS-soft segment melting temperature;  
Tm,HS-hard segment melting temperature. 
 
 




Analysis of the PAUs before the in vitro degradation revealed a microphase separated structure in 
the case of PAU1000 and PAU1500, characterized by a hard segment melting peak and the glass 
transition temperature (Tg) of the soft segment (Figure 4). PAU2000 was not microphase separated, 
showing only a melting peak originating from crystalline PCL-soft segment, indicating that the 
preferred mechanical properties typical for polyurethanes were virtually absent. 
Both PAU1500 and PAU2000 contained a relatively high fraction of crystalline PCL-soft segment 
(no Tg detectable of the soft segment of PAU2000) which could retard the hydrolytic degradation both 
in vitro and in vivo. The appearance of the soft segment melting peak in PAU1000 from day 50  
(Figure 4 & 5) on is a result of the chain scission and increased mobility of PCL-soft segments. Similar 
results have been observed earlier by different research groups [1,2,20]. 
Figure 5. Soft segment and hard segment melt enthalpies of PAUs upon degradation.  
(a) Soft segment melt enthalpy (ΔHm,SS); (b) Hard segment melt enthalpy (ΔHm,HS). 
 
However, the amount of crystalline PCL even after 80 days of degradation was negligible  
(Figure 5a) and it was not expected to influence PAU1000 degradation to a great extent. The soft 
segment crystallinity of PAU2000 gradually increased with incubation, most probably because some 
chain scission had occurred in the amorphous phase of the PAU2000, allowing for higher chain 
mobility. In addition, the overall mobility of the chains might have been facilitated by the long 
incubation (annealing) in the humid environment at 37 °C. 
PAU1000 exhibited the highest (bulk) hard segment crystallinity (Figure 5b), which remained 
constant during the course of degradation. 
2.3. Microphase Separation of PAUs Prior to Degradation (Trans-FTIR) 
Since hydrolytic degradation can only take place in the amorphous fraction of the polymer, the 
degree of microphase separation is one of the key factors that determine the hydrolysis rate of 
segmented polyester urethanes. To be able to determine which fraction of the hard segment was 
crystalline from the total urethane present (as a measure of the extent of the microphase separation), an 
enthalpy of melting of the 100% crystalline hard segment should be known. Since this was not the 
case, we attempted to calculate the extent of the microphase separation from the FTIR deconvolution 
analysis of the carbonyl absorption region of the PAUs. The carbonyl region was found to be suitable 




for this determination as described by Pretsch et al. [21]. Since only PAU1000 and PAU1500 
exhibited microphase separation, PAU2000 was excluded from the FTIR analysis. 
Bearing in mind that H-bond associated C=O always appears at the lower wavenumbers [21,22], 
and correlating the deconvolution results with the DSC observations (Figure 5), overlapping peaks in 
the C=O region were assigned as denoted in Figure 6. As already known from the literature, upon 
heating, dissociation of H-bonding occurs, followed by the disorder of the hard segment (HS) and soft 
and hard segment mixing [23,24]. The disruption of the HS crystallinity led to the decrease in the 
crystalline HS peak in both PAU1000 and PAU2000 (Figure 6). The decrease of the HS crystallinity 
was accompanied by the increase of the amorphous HS portion (Figure 6). As already observed by 
DSC, PAU1000 did not contain PCL soft segment (SS) in the crystalline form. The SS crystallinity of 
PAU1500 decreased upon heating, which resulted in the majority of the SS to be amorphous (Figure 6). 
Figure 6. Carbonyl region of PAUs (transmission Fourier Transform Infra Red (FTIR)) 
prior to degradation. (a) Assignment of peaks of the PAU1000 carbonyl region curve fit; 
(b) PAU1000–integral values of peaks with temperature increase; (c) PAU15000–integral 
values of peaks with temperature increase. 
 
If we observe the molecular structure of the PAUs (Scheme 1), we could suspect that the acyl 
carbonyls and the phenyl ring could engage in a resonance interaction, which would further result in 
coplanar intermolecular orientation and four different conformations (two cis and two trans). Acyl 




carbonyls would than rotate relatively freely around the single bond and the differences in the levels of 
vibration energies specific for the different conformers would be small. However, if such a system gets 
fixed in any way, the difference in energy levels of the conformers would become larger, which would 
result in the splitting of the acyl carbonyl band. Sun et al. observed this phenomenon by analyzing 
chemically similar polymers, poly[di(butyl) vinylterephthalate] (PDBVT) [25]. Due to the attachment 
of the phenyl ring to a polyvinyl backbone, the energy levels became further apart, leading to acyl 
carbonyl band splitting [25]. 
The acyl carbonyl group of the PAUs is located next to the urethane bond, and participates in the 
hydrogen bonding (H-bonding) of the HS. Since H-bonding of the HS prefers certain conformations 
above other ones, rotation of the acyl carbonyls from both sides of the phenyl ring becomes restricted. 
Temperature increase results in the disturbance of the H-bonds of the HS in the crystalline phase, 
which is detected as a decrease of peaks representing acyl carbonyl in the crystalline form, and an 
increase of peaks originating from acyl carbonyl in the amorphous form. Since associated carbonyls 
always appear at lower frequencies than their non-associated counterpart [22], the peak at 1771 cm−1 
has been assigned to H-bonded acyl carbonyl in the amorphous phase (Figure 6). The fact that these 
peaks increased with heating, indicated that it can only originate from the portion of the HS in the 
amorphous phase participating in the H-bonding with the amorphous SS. The other observed peak at 
1784 cm−1 probably originates from the non-associated acyl carbonyl of the HS in the amorphous 
phase (Figure 6). 
The HS crystallinity can be calculated using only peak integral values of the peaks originating from 
the urethane carbonyl group at 1680 cm−1 (Figure 6a, cryst. HS, peak designated as a) and 1718 cm−1 
(Figure 6a, amorph. HS, peak designated as c). However, since the acyl carbonyl peaks are a part of 
the HS and participate in the HS H-bonding, it seemed more accurate to combine the effect of the two 
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where ∫ stands for integral values of the peaks a, b, f, g and h as designated in Figure 6a. 








  100%  (4) 
As expected, a higher percentage of HS crystallinity was observed for PAU1000 with respect to 
PAU1500 (Table 1). 







PAU1000-0 57.5 0.4 
PAU1500-0 41.3 34.4 
*Calculated according to Equation 3. 
**Calculated according to Equation 4. 




In general, PAUs were less microphase separated than the PUs based on the same molar mass of 
PCL but with the HS comprised of BDI and BDO (HS cryst.(PCL1000-PU) = 73% and HS 
cryst.(PCL1600-PU) = 61%) [26]. In addition to more hydrolysable HS, this lower degree of 
microphase separation renders PAUs more susceptible to hydrolysis. 
2.4. Microphase Separation of PAUs Upon Degradation (ATR-FTIR) 
Since PAU1000 was distinctly more microphase separated compared to the PAU1500, the 
morphology and the surface properties of PAU1000 were analyzed in more detail. ATR-FTIR, being a 
surface sensitive technique, provided information on the changes at the PAU1000 interface, which 
properties determine the protein deposition and the cell contact in vivo [14,15,27]. The change of 
surface properties upon degradation was followed by ATR-FTIR with utilization of the similar 
deconvolution method derived from the transmission measurements (Section 2.3). Due to optical 
complications, deconvolution of ATR-FTIR spectra can only be seen as a semi-quantitative technique. 
However, since we used this method to compare samples of the same polymer during degradation by 
identical manipulation of all the collected spectra, we consider the method to be acceptably credible. In 
order to emphasize the contribution of the acyl functionality to the hydrolysis of the PAUs, we also 
plotted the percentage HS crystallinity without the contribution of the acyl carbonyl peaks (denoted e, f 








   (5) 
where ∫ stands for integral values of the peaks a and c as designated in Figure 6a. 
Compared to the HS crystallinity of non-degraded PAU1000 in the bulk (Table 1), crystallinity of the 
HS on the surface was lower (Figure 8) (in the bulk: 57.5%, on the surface ~30%), which indicated that 
the polar, crystalline HS was initially located away from the surface. Although the overall crystalline SS 
content was low, it was predominantly present at the surface (in the bulk, Table 1: 0.4%, on the surface, 
Figure 7: ~5%), which has been found before in other similar segmented polyurethanes [5,28]. 
With degradation, the crystallinity of both SS and HS increased at the surface. As already 
mentioned, hydrolysis can only occur in the amorphous portions of the PAUs. If the products of 
degradation would not diffuse out, the crystallinity of both SS and HS would remain the same. 
However, we did observe mass loss (Figure 1), which can solely be ascribed to the hydrolysis of the 
amorphous SS and HS and the diffusion of the degradation products preferentially from the surface. 
The SS crystallinity at the surface increased for ~30% after 80 days of degradation (Figure 7), which 
was far more than observed in the bulk (Figure 5a). As already mentioned, PAUs degraded partially 
via surface erosion mechanism. Preferential hydrolytic chain scission at the surface probably induced 
higher chain mobility at the surface that allowed for SS crystallization. PCL crystallization upon 
degradation was also observed by Lam et al. [2] and Antheunis et al. [20] 
Similar to the case of the SS crystallinity increase of PAU1000, the higher chain mobility at the 
surface of PAU1000 might also have allowed for better HS alignment, resulting in higher HS 
crystallinity at the surface relative to the bulk. Therefore, the increased crystallinity of both SS and HS 
upon degradation was most probably the result of both effects: Removal of the degradation products 




(mass loss) formed by ester and urethane bond hydrolysis in the amorphous portion of the PAUs,  
and the effect of the re-crystallization due to the higher mobility at the surface. The increased  
hydrogen-bonding capable hard HS content is expected to render the surface more hydrophilic, which 
is shown to further enhance cell adhesion [29,30]. 
Figure 7. Percentage hard (cryst. HS) and soft segment crystallinity (cryst. SS) upon 
degradation of PAU1000. (○) Soft segment (SS) crystallinity (calculated according to 
Equation 4); (∆) hard segment crystallinity with the contribution of the acyl carbonyl peak 
(HS-with Acyl) (calculated according to Equation 3); (▲) hard segment crystallinity 
without contribution of the acyl carbonyl peak (HS-without Acyl) (calculated according to 
Equation 5). 
 
2.5. Contact angle Measurements 
The increase in overall crystallinity at the surface of PAU1000 upon in vitro degradation and 
surface erosion were expected to result in the increased surface roughness. An increase of surface 
roughness can be detected as the contact angle increase. However, hydrolysis created polar functional 
groups (carboxyl, hydroxyl or amide) and increased HS content at the surface of the degraded 
PAU1000, both contributing to an increased hydrophylicity, which was observed by a decrease of the 
contact angle (Figure 8a). 
Somewhat lower contact angle values for non-incubated sample most probably originated from the 
different sample treatment in comparison to the rest of the data collected in the course of degradation 
(Figure 8a). After 50–60 days of degradation, the contact angle of PAU1000 was ~65°, which was 
close to optimal hydrophilicity conditions for cell adhesion and proliferation [29,30]. 
To model the biological environment of the potential PAU implant in vivo, the changes of the 
surface properties of PAU1000 in contact with biological fluids was investigated (Figure 8b). Coated 
on the Thermanox® cover slip, the contact angle of the PAU1000 in a dry state was 78.0° ± 2.6° while 
the angle of the Thermanox® cover slips was 71.1° ± 1.6° (Figure 8b). After incubation in PBS at  
37 °C for 1 h, and 18 h the contact angle had slightly decreased, but after the incubation in ECM and 
FCS a noticeable increase of surface hydrophylicity, compared to the non-incubated sample, was 
observed, with the contact angle of PAU1000 incubated in FCS reaching 45.0° ± 7.2° (Figure 8b). This 




increase of PAU1000 hydrophylicity could explain the best HUVEC adhesion result at longer culture 
time. After 18 h incubation in ECM, the PAU1000 surface contact angle was 60°, which is, according 
to the literature, an optimal value for the best cell adhesion [29]. Most probably surface hydrophobicity 
changed due to an increase in hard segment content on the PAU1000 surface as a result of the interaction 
of hard segment with water and proteins at the interface in combination with products of the surface 
erosion process. 
Figure 8. (a) Contact angle of PAU1000 during in vitro degradation; n = 5; data expressed 
as mean ± standard error of the mean; (b) Contact angle of PAU1000 exposed to biological 
fluids: Phosphate buffer saline (PAU1000 in PBS), endothelial cell culture medium 
(PAU1000 in ECM) and fetal calf serum (PAU1000 in FCS). References included:  
non-incubated PAU1000 (Non-incub. PAU1000) and non-incubated Thermanox®  
(Non-incub. Therm). All the values, except where indicated (n.s.) were statistically 
significantly different (n = 5; data expressed as mean ± standard error of the mean). 
 
Upon implantation, PAU1000 performance is expected to be a result of a complex interplay 
between the material surface properties, protein deposition and a type of cells involved. 
2.6. Cytotoxicity (MTS Assay) 
In this study, we performed a reliable and robust method of determining cytotoxicity of the novel 
polyacylurethane PAU1000. Mitochondrial activity of PK-84 cells cultured in the medium containing 
extracts from PAU1000 was similar to both positive control and the blank, which was set to 100%,  
i.e., non-toxic, showing that PAU1000 was non-cytotoxic (Table 2). 
Table 2. Cytotoxicity determination. Cytotoxicity of PAU1000 was comparable to clinical 
grade polyurethane Pellethane®. Controls were Latex (cytotoxic) and medium (non-toxic) 
(n = 4, data expressed as average ± SD). 
[Test material Cell survival [%] 
PAU1000 86 ± 6 
Pellethane® 91 ± 6 
Latex 38 ± 1 
Medium 104 ± 13 





The rate of thrombin generation by PAU1000 was similar to low density polyethylene, which is 
lowly thrombogenic, and much lower than polydimethylsiloxane, which served as i.e., thrombogenic 
control material (Figure 9a). The other PCL-based PU, PU1000, was the least thrombogenic of all the 
materials tested. Since both the clotting cascade and platelet phospholipids were involved in this test, 
the results are clinically relevant. The good haemocompatibility renders PAU1000 a promising 
candidate for cardiovascular applications, e.g., bioartificial vascular grafts. 
Complement convertases are formed by incubating biological fluids, blood or blood products with 
biomaterials, allowing the activation of the complement system and binding of complement 
convertases to the biomaterial surface. Surface activity of the C5 convertase indicates generation of 
C5a fragments, which are strong anaphylactic and chemotactic components and initiation of C5b-9, the 
terminal complement complex with cytotoxic capacity. Activation of the complement cascade in the 
presence of PAU1000 was measured through the activity of complement C5 convertase on the material 
surface. In this respect, PAU1000 only minimally activated complement compared to the other control 
biomedical materials (Figure 9b). Both PUs induced very low complement convertase activity. 
Therefore, the low C5 convertase activity recorded in the experiment with PAU1000 would be 
predicted to induce only a minimal inflammatory reaction in vivo. 
Figure 9. Haemocompatibility assessment. (a) Thrombin generation assay; (b) C5 complement 
convertase activity. Control materials used for comparison: 1,4-butanediisocyanate based 
polyurethane (PU1000), polydimethylsiloxane (PDMS) and low density polyethylene (LDPE) 
as the Gold standard (mean values of duplicate measurements ± SD). 
 
2.8. HUVEC Adhesion to PAU1000 
Adhesion of human umbilical vein endothelial cells (HUVEC) to PAU1000 was monitored for 18 h. 
Based on the hydrophobic nature of PAU1000, we expected only a low adhesion of HUVEC to the PU. 
However, the difference in contact angle values between PAU1000 (78.0° ± 2.6°) and Thermanox® 
cell culture treated cover slips (71.1° ± 1.6°) was similar. Thus, in this setting hydrophobicity was not 
the only parameter governing the cell adhesion. We assume that the presence of carboxyl functionality 
on the surface of Thermanox® cover slips rendered the surface more cell-adhesive. In order to further 
enhance cell adhesion, we included samples that were additionally coated with fibronectin. Fibronectin 




possesses integrin binding motifs such as the RGD (Arg-Gly-Asp) sequence that could augment the 
attachment of HUVEC [31,32]. Initially, the number of adhered cells increased regularly with time, 
irrespectively of Fn-coating, with Fn-coated PAU1000 cover slips providing faster cell adhesion for 
the period up to 4 h (Figure 10a). 
Figure 10. Adhesion and proliferation of endothelial cells (HUVEC) on PAU1000.  
(A) HUVEC adhesion to PAU1000 (■) and Fn-coated PAU1000 (▲) monitored up to  
18 h. (n = 3; 6 images per cover slip, data expressed as mean ± standard error of the mean; 
asterisks indicate significant differences *p < 0.05); (B) Viability test of HUVEC during 
adhesion to PAU1000 and Fn-coated PAU1000 (PAU1000+Fn) at 4 and 8 h (n = 2;  
6 images per cover slip, data expressed as mean ± standard error of mean; asterisks 
indicates significant difference *p < 0.05 ); (C) HUVEC proliferation after 25 h culture on 
PAU1000, Fn-coated PAU1000, Thermanox® cover slips (Therm) and Fn-coated 
Thermanox® cover slips (Therm+Fn) (n = 2; 5 images per cover slip, data expressed as 
mean ± standard error of the mean). 
 
HUVEC cultured on PAU1000 exhibited a steady increase in the number of adhered cells, resulting 
in a similar degree of adhered HUVEC on both Fn-coated and bare PAU1000. In order to elucidate the 
observed phenomenon of decrease of cell adhesion between the points 4 h and 8 h, the viability was 
measured using Trypan blue dye exclusion. The number of viable cells that adhered after incubation 
was at both time points more than 80% (Figure 10b), which was similar to the other time points (data 
not shown). Although the cells remained viable throughout the test period, some had detached from the 
Fn-coated slips after 8 h of culture. Since Fn is hydrophobic, a property that does not depend on the 




nature of the underlying substrate [33], the hydrophobic interaction of Fn with PAU1000 is strong. 
These strong hydrophobic interactions could have caused adverse conformational changes in the Fn 
molecules that impaired cell adhesion. Furthermore, the Fn-coating might have been partially lost 
during prolonged culturing, thus exposing the cells to the less adhesive bare surface of the PAU1000. 
In the later stages of incubation, adhering HUVEC started producing their own adhesive extracellular 
matrix molecules such as collagen and fibronectin (data not shown) [34]. This cellular activity might 
be the reason why with prolonged culture time (overnight), the difference between the HUVEC 
adhesion to bare PAU1000 and Fn-coated PAU1000 was diminished (Figure 10a). 
A possible explanation for low cell adhesion to PUs could be that the PU surface exposed to plasma 
proteins is mostly covered with proteins that are generally considered non-adhesive. Fibrinogen is 
initially adhered, but it is competed for deposition on the polyurethane surface with albumin,  
high-density lipoprotein and high molecular weight kininogens (HMWK), which all do not favor cell 
binding [35]. The dynamics of the rearrangement and replacement of proteins on the PU surface is 
determined by the hydrophobicity and the degree of polyurethane micro-phase separation [10,34,36,37]. 
This influences protein mobility and rearrangement for better recognition by cell integrins [34]. 
Proteins interact with the polyurethanes via hydrophobic interactions (soft segment domains) and/or 
hydrogen bonding (hard segment). Highly hydrophobic substrates bind more protein as compared to 
more hydrophilic substrates. The hard segments are reported to bind fibrinogen via hydrogen  
bonds [36]. Being more adhesive, the hard segment is also known to interact with platelets and lead to 
their activation [28,37]. To contribute to the complexity of polyurethane-protein and cell interaction, a 
polyurethane surface is also dynamic and might rearrange to promote better adhesive properties by 
exposure of hard segments. A dry PU surface, being in contact with air, which is hydrophobic, has soft 
segments mostly exposed [5]. Upon immersion in water, more polar hard segments capable of 
hydrogen bonding migrate to the surface, making it more hydrophilic. The decrease in contact angle 
was observed for PAU1000 upon contact with biological fluids (Figure 8). 
2.9. HUVEC Proliferation on PAUs 
Even though the rate of HUVEC adhesion may appear low, longer incubation experiments of 25 h 
revealed that both bare PAU1000 and Fn-coated PAU1000 allowed for significant HUVEC 
proliferation, reaching almost 50% cellular confluence already after 25 h of culture, which was similar 
to the Thermanox® cover slips (Figure 10c). That indicates that fast and efficient in vitro 
endothelialization of grafts fabricated from PAU1000 is feasible. The additional coating with Fn 
appeared to further increase the number of proliferating cells on PAU1000, although it had little 
influence on Thermanox® cover slips. 
3. Experimental Section 
3.1. Materials 
ε-Caprolactone (CL) was obtained from Union Carbide (Terneuzen, The Netherlands) and was 
purified by distillation under reduced pressure from calcium hydride (CaH2). Terephthaloyl 
diisocyanate was synthesized from terephthalamide, obtained from TCI (Japan) and oxalyl chloride 




from Sigma-Aldrich (Zwijndrecht, The Netherlands) using a modified method of Tsuge et al. [38]. 
Analytical grade 1,4-butanediol (BDO) was purchased from Sigma-Aldrich (Zwijndrecht, The 
Netherlands) and purified by distillation from 3 Å mole sieves under reduced pressure. Chloroform, 
diethyl ether, dimethyl formamide and n-hexane as analytical grade solvents were purchased from 
Acros Organics (Geel, Belgium) and were used without further purification. Sodium azide was 
purchased from Sigma-Aldrich (Zwijndrecht, The Netherlands) and used as received. 
Polyacylurethane films were cast from chloroform onto PFA Petri dishes (perfluoroalkoxy polymer 
resin) obtained from Bergof (Florida, USA). 
Thermanox® cover slips which were purchased from NUNC™ (Roskilde, Denmark). 
Glutaraldehyde was purchased from Sigma-Aldrich (Zwijndrecht, The Netherlands). RPMI medium 
and fetal calf serum (FCS) were obtained from Cambrex Bio Science (Verviers, Belgium). CellTiter 
96® Aqueous One Solution A was purchased from Promega Corporation (Madison, WI, USA). 
Polyurethane Pellethane® was a gift from Dow Chemicals (Midland, MI, USA). 
The following materials were used in the haemocompatibility study: Polydimethylsiloxane (PDMS) 
from Eriks (Alkmaar, The Netherlands), low-density polyethylene (LDPE) ET311350 from 
Goodfellow (Cambridge, UK), thrombin chromogenic substrate S2238 and chromogenic substrate S2527 
from Chromogenix (Milano, Italy). 
In cell adhesion and proliferation tests the following materials have been employed:  
Diamidino-2-phenylindol-dihydrochlorid (DAPI) from Sigma-Aldrich (Germany), Triton X-100 from 
Sigma (St. Louis, USA), polyclonal antibody rabbit-anti Ki-67 from Nova Castra Laboratory 
(Newcastle, UK), Tween 20 from Sigma-Aldrich (Zwijndrecht, The Netherlands), Avidin/Biotin 
blocking kit from Vector Laboratories Inc. (CA, USA), streptavidin-FITC from DAKO (The 
Netherlands) and Citifluor API from Agar Scientific (Essex, UK). 
3.2. Synthesis of Polyacylurethanes 
Polyacylurethanes (PAUs) were synthesized by a slightly modified method of Heijkants et al. [8]. 
The synthesis was performed in two steps: 1) oligodiol synthesis and 2) polymerization of the oligodiol 
with terephthaloyl diisocyanate (TPHDI) (Scheme 1). The oligodiols, poly(ε-caprolactone) (PCL) diols 
of three different lengths (1000, 1500 and 2000 g/mol) were prepared by thermal polymerization 
employing 1,4-butanediol as an initiator without the use of any catalyst at 150 °C for 7 days under 
argon [26]. The second step was performed in the Micro Twin Extruder. Briefly, a powder mixture of 
PCL (molar mass = 1000 g/mol) (approximately 7.0 g; 7.0 mmol) and TPHDI (0.75 g; 3.5 mmol) was 
fed to a micro-extruder at 65 °C. Subsequently, the extruder was heated up to 130 °C and another 
portion of TPHDI (0.75 g) was added. The average polymerization time was 6 minutes; the resulting 
polymer was collected, purified by precipitation in diethyl ether from chloroform solution, and dried in 
a vacuum stove at 40 °C. The reaction scheme is depicted in Scheme 1. 




Scheme 1. Synthesis of polyacylurethanes. Terephthaloyl diisocyanate (TPHDI) and 
poly(ε-caprolactone) (PCL) are reacted without a catalyst to yield polyacylurethane (PAU). 
 
3.3. Preparation of Polymer Films 
Polymer films were prepared by casting a 2 w/v% polyurethane solution in chloroform onto either 
ID 8 cm PFA Petri dishes or Thermanox® cover slips (treated side up) at room temperature. Both the 
freestanding films and the coated slips were washed in a Soxhlet apparatus utilizing n-hexane as the 
extraction solvent for 16 h in order to remove any surface contaminants such as potentially present 
silicones. Finally, the materials were dried and stored in the vacuum stove at 40 °C until further use. 
In some of the experiments, PAU-coated Thermanox® cover slips were additionally coated with 
fibronectin (Fn). In brief, 250 μL of 1 weight% solution of recombinant human Fn in PBS was placed 
in wells (24-wells culture plate) containing PAU-coated slips and incubated at 37 °C for 30 min. The 
excess of Fn-solution was aspirated and the adhered fibronectin was cross-linked with 0.5% 
glutaraldehyde (GA) solution in PBS at room temperature for 15 min. In order to remove all the GA 
remains, all the coated samples were extensively washed with PBS and endothelial cell culture 
medium (ECM medium) formulated in our laboratory. The endothelial culture medium (ECM) 
consisted of RPMI 1640 supplemented with 20% heat-inactivated FSC, 2 mM L-glutamine, 5 U/mL 
heparin, 100 IE/mL penicillin and 100 μg/mL endothelial growth factor supplement extracted  
from bovine brain. 
3.4. In Vitro Degradation Set-Up 
Films obtained as described above were cut in quarters and weighed. Subsequently, each piece 
was placed in a glass container and 100 mL of phosphate buffer (solution in water, pH = 7.2; 
Sigma-Aldrich, Zwijndrecht, The Netherlands) solution, containing 0.02 wt% of sodium azide, was 
added. Labeled and well-closed containers were placed in a dark water bath at 37 °C. At 
predetermined time points, starting from 5 up to 80 days, samples (n = 2 per time point) were taken 
and rinsed with distilled water and blotted gently with tissue paper to remove surface water. 
Subsequently, the samples were dried in a vacuum oven at 40 °C. The weight was monitored until 
it reached a constant value. 




3.5. Mass Loss 
The mass loss of PAU-films upon in vitro degradation was determined by weighing the samples 








100%  (6) 
Where mo is the dry mass before incubation and md is the dry mass after degradation. 
3.6. Molar Mass 
The molar masses of the PAUs after synthesis and purification, as well as the molar masses of 
samples (n = 2 films per time point) upon degradation were determined by gel permeation 
chromatography (GPC) utilizing a Waters 600 Powerline system, equipped with 2 mixed-C Pl-gel 5 μ 
columns employing dimethyl formamide (DMF) with 0.01 M LiBr as eluent at 70 °C. The data 
analysis was done using conventional calibration with polystyrene standards accompanied by in-house 
software. Number average molar mass (Mn) data (average of two samples per time point) were fitted 
by using the OriginPro 7.5 software. 
3.7. Thermal Properties of PAUs 
Thermal properties of PAUs as polymerized and at different time points of degradation were 
measured with a differential scanning calorimeter Q 1000 from TA Instruments. The samples with 
masses varying between 7–10 mg were heated from −85 °C to + 150 °C with a rate of 10 °C/min. The 
data collected during the first heating run were analyzed utilizing the TA Instruments software version 4.0. 
3.8. Fourier-Transform Infra Red Spectroscopy (FTIR) 
All the infrared spectral manipulation was performed using the Opus v.4.2 software package 
(Bruker Optik GmbH). 
Infrared transmission measurements were done on films cast on KBr pellets from chloroform 
solution using a Bruker IFS88 spectrometer equipped with a MCT-A detector at the resolution of  
2 cm−1. The KBr pellets were measured horizontally using the Bruker infrared microscope accessory. 
Five hundred scans were recorded per spectrum. Temperature was varied from room temperature to 
120 °C. 
The carbonyl absorption region from 1850 cm−1 to 1575 cm−1 was deconvoluted by fixing the peak 
position and allowing for peak intensity, width and shape to be optimized by the Opus software. The 
Levenberg-Marquardt algorithm was used in curve fit optimization. The calculated residual RSM 
fitting error was always <0.009. 
ATR-FTIR was done using a Bruker IFS88 spectrometer equipped with a Golden Gate (Graseby 
Specac) single reflection ATR accessory. Spectral resolution was 4 cm−1 and 50 scans were taken  
per spectrum. 




3.9. Contact angle Measurements 
Surface properties of PAU1000 were assessed during the in vitro degradation up to a period of  
80 days and upon short-term exposure to biological fluids. For the latter, PAU1000-coated 
Thermanox® cover slips were placed in the wells of a 24-well culture plate and incubated in PBS, 
ECM supplemented with 20% FCS and 100% FCS at 37 °C for 1 h, and 18 h. In both cases, after 
incubation the samples were rinsed by means of spraying distilled water against both sides of the 
samples. The samples were blotted with tissue paper, free-standing film or cover slips were fixed to 
glass slides by double-sided adhesive tape and contact angle was measured using a sessile drop method 
using a Krüss Drop Shape Analysis System DSA 10. 
3.10. MTS Cytotoxicity Assay 
To perform cytotoxicity assays, a fibroblast cell line PK84 was cultured in RPMI medium 
containing 10% FCS. Cells seeded in a density of 5,000 cells/well were exposed to an extract of 
PAU1000, obtained by shaking the material overnight in culture medium at 37 °C. After 48 h 20 μL of 
CellTiter 96® Aqueous One Solution A was added to each well and the absorbance intensity was 
recorded at 490 nm after 90 min of culture. Pellethane® and latex were used as negative and positive 
control, respectively. 
3.11. Haemocompatibility of PAU 
Two different methods were employed to assess the blood compatibility of PAU1000: Thrombin 
generation assay and Complement convertase activity. Another biomedical polyurethane developed in 
our laboratory by Heijkants et al. [26] (1,4-butanediisocyanate-based (BDI) hard segment and  
PCL-based soft segment) with the same PCL length as PAU1000, and commonly used reference 
materials were included in the experiments. 
The formation of thrombin in the presence of the biomaterial was determined by means of the 
Thrombin Generation Assay (TGA) as developed by Haemoscan (Groningen, The Netherlands). 
Polydimethylsiloxane (PDMS) and low-density polyethylene (LDPE) were used as positive and 
negative control, respectively. Thrombin generation was obtained in citrate plasma depleted of 
fibrinogen. Materials (surface area 0.5 cm2) were incubated in duplicate in 350 μL plasma in 
polyethylene tubes for 15 min at 37 °C. Then CaCl2 (30 mM) and phospholipids were added, gently 
mixed and after 1, 2, 4 and 6 min, 10 μL of the incubation mixture was diluted in 490 μL ice cold  
25 mM Tris-HCl buffer to stop further thrombin formation or inhibition. These diluted samples were 
incubated at 37 °C with 3 mM thrombin chromogenic substrate S2238 for 20 min. The optical density of 
the yellow color was measured at 405 nm in a micro titer plate reader from Powerwave 200 Bio-Tech 
Instruments (Winooski, Vermont). A calibration curve was made with known concentrations of 
thrombin in Tris buffer.  
Surface-bound C5 convertase was determined on 1 cm2 material after incubation in porcine plasma 
for 15 min at room temperature (CCA, Haemoscan, Groningen, The Netherlands). After incubation, 
the samples were rinsed and incubated in chromogenic substrate S2527) diluted in TRIS buffer at room 




temperature in the dark for 24 h. Thereafter, the optical density was determined at 405 nm in a 
microplate reader. 
3.12. HUVEC Adhesion and Viability on PAU1000 
Human umbilical vein endothelial cells (HUVEC) were isolated and cultured as previously 
described [39]. In short, the cells were cultured on endothelial culture medium (ECM; see Section 3.3) 
and 1% gelatin coating at 37 °C and 5% CO2. Polyurethane (PAU1000)-coated Thermanox® cover 
slips and additionally fibronectin (Fn)-coated cover slips were placed in 24-well plates and HUVEC 
(130.000/cm2) were seeded in each well. After 18 h of culture, adhered cells were fixed in 2% 
paraformaldehyde (PFA) in PBS at room temperature for 20 min. Cells were stained with DAPI in 
PBS for 30 min. The cell number was determined by fluorescence microscopy utilizing Leica DC 300F 
apparatus (Wetzlar, Germany). For the viability test, HUVEC (150.000/cm2) in ECM were seeded onto 
either PAU1000-coated cover slips, or Fn-coated PAU1000 cover slips, and cultured for 4 and 8 h. The 
adhered cells were detached with trypsin and the viability was assessed using Trypan blue staining. 
3.13. HUVEC Proliferation on PAU1000 
The HUVEC proliferation was evaluated upon culture on PAU1000, Fn-coated PAU1000, bare 
Thermanox® cover slips and Fn-coated Thermanox® cover slips for 25 h. After culture, the  
non-adhered cells were removed by washing and the attached cells were fixed with 2% PFA in PBS 
and stored dry at 4 °C. For the staining, samples were thawed, dried and additionally fixed with 2% 
PFA in PBS. Fixed cells were permeabilized with 0.5% Triton X-100 in PBS. Samples were then 
incubated with polyclonal antibody rabbit-anti Ki-67 (1:500) at room temperature for 90 min. 
Subsequently, cells were washed with 0.05% Tween 20 in PBS. Endogenous avidin and biotin were 
blocked with Avidin/Biotin blocking kit for 15 min each. Samples were then incubated with the 
secondary antibody goat anti rabbit biotin in DAPI/PBS solution at room temperature in the dark for 
30 min. Thereafter, cover slips were incubated with streptavidin-FITC in DAPI/PBS at room 
temperature in the dark for 30 min. All incubation steps were followed by appropriate washing steps. 
The cover slips were transferred and fixed onto glass slides, and mounted in Citifluor API. The cover 
slips were examined by immunofluorescence microscopy using a Leica DMRXA microscope and 
Leica Software of Leica Microsystems (Wetzlar, Germany). At least six images were recorded per 
cover slip and the attached cells were counted. 
Due to the high auto fluorescence of uncoated PAU1000, we also detached the cells after overnight 
culture and cytospotted the cells on glass slides for 5 min and speed of 500 rpm using Shendon, 
Cytospin 3 apparatus. The staining procedure for Ki67 was the same as previously mentioned. 
3.14. Statistical Analysis 
A statistical analysis was performed by two-way ANOVA followed by Bonferroni post hoc analysis 
using GraphPad Prism software v4 (San Diego, California, USA). Values of p < 0.05 were considered 
statistically significant. 





Polyacylurethanes (PAUs) degraded in vitro via combined bulk and surface erosion mechanisms. 
Due to a faster hydrolysable hard segment based on terephthaloyl diisocyanate and lower degree of 
microphase separation, PAUs degraded much faster in vitro than comparable PUs with the same 
polyester (PCL) soft segment. Predominant chain scission at the surface led to different surface 
properties of PAUs with respect to the bulk. Surface erosion and increased chain mobility at the 
surface resulted in the increase of both soft and hard segment crystallinity upon degradation. 
Generation of the polar groups upon hydrolysis and the increase of the hard segment content on the 
surface probably led to the increase in hydrophilicity, which further renders PAU1000 potentially cell 
adhesive. PAU1000 (molar mass of the oligocaprolactone soft segment = 1000 g/mol) can be 
recommended as a potential scaffold material to be used in regenerative medicine due to its optimal  
in vitro behavior. PAU1000 behaved as a non-toxic and blood-compatible biomaterial. In addition, 
PAU1000 supported adhesion and proliferation of human umbilical vein endothelial cells. Taken 
together, these results support the application of PAU1000 in the field of soft tissue repair as a 
temporary degradable scaffold. 
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